A Randomized, International, Multi-center, Open-label Study to Document Optimal Timing of Initiation of Dronedarone Treatment After Conversion With Loading Dose of Amiodarone in Patients With Persistent Atrial Fibrillation Requiring Conversion of AF.

Trial Profile

A Randomized, International, Multi-center, Open-label Study to Document Optimal Timing of Initiation of Dronedarone Treatment After Conversion With Loading Dose of Amiodarone in Patients With Persistent Atrial Fibrillation Requiring Conversion of AF.

Completed
Phase of Trial: Phase IV

Latest Information Update: 29 Dec 2012

At a glance

  • Drugs Dronedarone (Primary) ; Amiodarone
  • Indications Atrial fibrillation
  • Focus Pharmacogenomic; Therapeutic Use
  • Acronyms ARTEMIS AF Loading
  • Sponsors Sanofi
  • Most Recent Events

    • 07 Nov 2012 Results presented at the 85th Annual Scientific Sessions of the American Heart Association.
    • 28 Jun 2012 Additional locations added as reported by European Clinical Trials Database.
    • 20 Jan 2012 Actual patient number (402) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top